RedHill Biopharma Ltd. (RDHL) is a specialty biopharmaceutical company based in Tel Aviv, Israel, dedicated to the development and commercialization of innovative therapeutic solutions for gastrointestinal and infectious diseases. With a robust pipeline that includes both proprietary products and strategic partnerships, RedHill aims to address significant unmet medical needs while leveraging advanced clinical research and regulatory expertise. The company's commitment to improving patient outcomes positions it as a key player in the biopharmaceutical sector, targeting both niche markets and broader applications in healthcare.